Live from the NIH registry
Studies recruiting near Hartford right now
Top 25 of 443 recruiting studies, sorted by proximity — each links to its official registry page
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Acute Leukemia, Newly Diagnosed
N/A
Observational 1,365 participants sought
Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (0.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Spinal Disease, Degenerative Disc Disease
N/A
Observational 120 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: Collagen Matrix
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Alcohol Use Disorder, Cannabis Use Disorder
N/A
Interventional 294 participants sought
UConn Health — Farmington, Connecticut (8.3 mi)
· Sponsor: Massachusetts General Hospital
Accuracy of Lactate Meter in GSDIa
Glycogen Storage Disease Type Ia
N/A
Observational 10 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (0.2 mi)
· Sponsor: Connecticut Children's Medical Center
CLOZAPINE Response in Biotype-1
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 524 participants sought
Hartford Healthcare — Hartford, Connecticut (0.2 mi)
· Sponsor: University of Texas Southwestern Medical Center
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Starling Physicians — Hartford, Connecticut (0.2 mi)
· Sponsor: Pfizer
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Agitation
Phase 2
Interventional 150 participants sought
Elixia MA, LLC — Springfield, Massachusetts (23.7 mi)
· Sponsor: Teikoku Pharma USA, Inc.
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Connecticut Children's Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: Giselle Sholler
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
Hartford HealthCare Cancer Institute — Hartford, Connecticut (0.2 mi)
· Sponsor: Kura Oncology, Inc.
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (0.2 mi)
· Sponsor: Janssen Research & Development, LLC
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Gastroenterolgy Center of Conneticut — Hamden, Connecticut (27.9 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Charcot Marie Tooth Disease
N/A
Observational 5,000 participants sought
University of Connecticut/Connecticut Children's Medical Center — Hartford, Connecticut (0.2 mi)
· Sponsor: Michael Shy
Multifidus Cervicis Plane Block Vs. Sham Block For Posterior Cervical Spine Fusion Surgery
Cervical Spine Fusion
Phase 4
Interventional 38 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: Hartford Hospital
Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
Obesity
N/A
Interventional 164 participants sought
Hartford HealthCare — Hartford, Connecticut (0.2 mi)
· Sponsor: Hartford Hospital
A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia
Hemiplegia, Cerebral Palsy
N/A
Interventional 30 participants sought
Physical Therapy Program, Department of Kinesiology, University of Connecticut — Storrs, Connecticut (22.5 mi)
· Sponsor: University of Connecticut
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Waterbury, Connecticut (23.8 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (0.2 mi)
· Sponsor: SWOG Cancer Research Network
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Schizophrenia, Bipolar I Disorder
Phase 3
Interventional 220 participants sought
Alkermes Investigator Site — Hartford, Connecticut (0.2 mi)
· Sponsor: Alkermes, Inc.
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 798 participants sought
Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut — Plainville, Connecticut (11.0 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (0.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 130 participants sought
University of Connecticut Health Center — Farmington, Connecticut (8.3 mi)
· Sponsor: Johnson & Johnson Enterprise Innovation Inc.
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Medical Research Center of Connecticut — Hamden, Connecticut (27.9 mi)
· Sponsor: Eli Lilly and Company